175 related articles for article (PubMed ID: 27426130)
21. The indexing potential of histone lysine methylation.
Schotta G; Lachner M; Peters AH; Jenuwein T
Novartis Found Symp; 2004; 259():22-37; discussion 37-47, 163-9. PubMed ID: 15171245
[TBL] [Abstract][Full Text] [Related]
22. Development and classes of epigenetic drugs for cancer.
Dhanak D; Jackson P
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):58-69. PubMed ID: 25016182
[TBL] [Abstract][Full Text] [Related]
23. Insights into the epigenetic mechanisms involving histone lysine methylation and demethylation in ischemia induced damage and repair has therapeutic implication.
Chakravarty S; Jhelum P; Bhat UA; Rajan WD; Maitra S; Pathak SS; Patel AB; Kumar A
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):152-164. PubMed ID: 27664837
[TBL] [Abstract][Full Text] [Related]
24. Active genes are tri-methylated at K4 of histone H3.
Santos-Rosa H; Schneider R; Bannister AJ; Sherriff J; Bernstein BE; Emre NC; Schreiber SL; Mellor J; Kouzarides T
Nature; 2002 Sep; 419(6905):407-11. PubMed ID: 12353038
[TBL] [Abstract][Full Text] [Related]
25. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.
Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760
[TBL] [Abstract][Full Text] [Related]
26. Histone lysine methylation patterns in human cell types are arranged in distinct three-dimensional nuclear zones.
Zinner R; Albiez H; Walter J; Peters AH; Cremer T; Cremer M
Histochem Cell Biol; 2006 Jan; 125(1-2):3-19. PubMed ID: 16215742
[TBL] [Abstract][Full Text] [Related]
27. Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.
Tian X; Zhang S; Liu HM; Zhang YB; Blair CA; Mercola D; Sassone-Corsi P; Zi X
Curr Cancer Drug Targets; 2013 Jun; 13(5):558-79. PubMed ID: 23713993
[TBL] [Abstract][Full Text] [Related]
28. Deciphering the interplay of histone post-translational modifications in cancer: Co-targeting histone modulators for precision therapy.
Kawaf RR; Ramadan WS; El-Awady R
Life Sci; 2024 Jun; 346():122639. PubMed ID: 38615747
[TBL] [Abstract][Full Text] [Related]
29. Small molecule modulators of histone acetylation and methylation: a disease perspective.
Selvi BR; Mohankrishna DV; Ostwal YB; Kundu TK
Biochim Biophys Acta; 2010; 1799(10-12):810-28. PubMed ID: 20888936
[TBL] [Abstract][Full Text] [Related]
30. The epigenetic magic of histone lysine methylation.
Jenuwein T
FEBS J; 2006 Jul; 273(14):3121-35. PubMed ID: 16857008
[TBL] [Abstract][Full Text] [Related]
31. Targeting Histone Methylation in Cancer.
McCabe MT; Mohammad HP; Barbash O; Kruger RG
Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
[TBL] [Abstract][Full Text] [Related]
32. A methylation rendezvous: reader meets writers.
Brenner C; Fuks F
Dev Cell; 2007 Jun; 12(6):843-4. PubMed ID: 17543855
[TBL] [Abstract][Full Text] [Related]
33. Chemical biology and pharmacology of histone lysine methylation inhibitors.
Barghout SH; Machado RAC; Barsyte-Lovejoy D
Biochim Biophys Acta Gene Regul Mech; 2022 Aug; 1865(6):194840. PubMed ID: 35753676
[TBL] [Abstract][Full Text] [Related]
34. Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives.
Song Y; Wu F; Wu J
J Hematol Oncol; 2016 Jun; 9(1):49. PubMed ID: 27316347
[TBL] [Abstract][Full Text] [Related]
35. Hitting the 'mark': interpreting lysine methylation in the context of active transcription.
Wozniak GG; Strahl BD
Biochim Biophys Acta; 2014 Dec; 1839(12):1353-61. PubMed ID: 24631869
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
37. Demethylation of histone H3K36 and H3K9 by Rph1: a vestige of an H3K9 methylation system in Saccharomyces cerevisiae?
Klose RJ; Gardner KE; Liang G; Erdjument-Bromage H; Tempst P; Zhang Y
Mol Cell Biol; 2007 Jun; 27(11):3951-61. PubMed ID: 17371840
[TBL] [Abstract][Full Text] [Related]
38. Histone methylation in pancreatic cancer and its clinical implications.
Liu XY; Guo CH; Xi ZY; Xu XQ; Zhao QY; Li LS; Wang Y
World J Gastroenterol; 2021 Sep; 27(36):6004-6024. PubMed ID: 34629816
[TBL] [Abstract][Full Text] [Related]
39. The emerging role of KDM5A in human cancer.
Yang GJ; Zhu MH; Lu XJ; Liu YJ; Lu JF; Leung CH; Ma DL; Chen J
J Hematol Oncol; 2021 Feb; 14(1):30. PubMed ID: 33596982
[TBL] [Abstract][Full Text] [Related]
40. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
